More News

02 Apr 2020 Evotec Expands its iPSC-Based Cell Therapy Platform EVOcells Through Licensing Agreement with panCELLa
02 Apr 2020 AC Immune Presents the Latest Preclinical Data on Novel Drug Targets for Neurodegenerative Diseases
01 Apr 2020 Neurimmune and Ethris Sign Collaboration Agreement to Rapidly Develop Inhaled mRNA-based Antibody Therapy for the Treatment of COVID-19
01 Apr 2020 Daiichi Sankyo Enters into Strategic Partnership with Ultragenyx for Use of Gene Therapy Manufacturing Technology
01 Apr 2020 REGENXBIO and Ultragenyx Announce New License Agreement for Use of NAV® Technology Platform for the Treatment of Rare Metabolic Disorder
01 Apr 2020 Lilly and Sitryx Announce Licensing and Research Collaboration to Discover and Develop New Immunometabolic Medicines
27 Mar 2020 CG Oncology Announces License and Commercialization Agreement with Kissei Pharmaceutical Co., Ltd. for CG0070 in Japan and Other Asian Countries
26 Mar 2020 ReCode Therapeutics Raises $80 Million in Oversubscribed Series A Financing
26 Mar 2020 Evox Therapeutics and Takeda sign multi-target rare disease collaboration
26 Mar 2020 Saniona enters into second collaboration agreement with Boehringer Ingelheim in schizophrenia
26 Mar 2020 Laekna Acquires Exclusive Global Rights to Clinical-Stage Cancer Asset
26 Mar 2020 Forge Enters Into Collaboration With Roche To Develop Novel Antibiotic To Treat Lung Infections
26 Mar 2020 Debiopharm Expands Its Radiopharmaceutical Footprint with an Exclusive In-Licensing Agreement of 3B Pharmaceutical's Targeted CAIX Radiotherapy
26 Mar 2020 Alector Enters into a Licensing Agreement with Innovent Biologics to Develop and Commercialize AL008 in Oncology Indications in China
25 Mar 2020 AstraZeneca to discover and develop siRNA therapeutics for Cardiovascular, Renal, Metabolic and Respiratory diseases in new collaboration
24 Mar 2020 CytomX Therapeutics and Astellas Announce Strategic Collaboration to Develop Probody® T-Cell Engaging Bispecific Therapies for Treatment of Cancer
24 Mar 2020 Pieris Pharmaceuticals Provides Update on Servier Collaboration
24 Mar 2020 Secarna Pharmaceuticals announces the acquisition of LNAplus based antisense drug candidates by Lipigon Pharmaceuticals
23 Mar 2020 Codexis Signs Strategic Collaboration and License Agreement with Takeda to Advance Novel Gene Therapies for Rare Genetic Disorders
23 Mar 2020 NeoImmuneTech Enters into Exclusive License Agreement with Ubix Therapeutics to Develop Drug Candidates Including T Cell Suppressor Blockade
23 Mar 2020 Bayer and Curadev sign research collaboration and license agreement to develop novel STING antagonists across indications
18 Mar 2020 Immatics Announces Business Combination with Arya Sciences Acquisition Corp., Creating a Publicly Listed Leader in TCR-based Immunotherapies
18 Mar 2020 RIBOMIC Enters License Agreement with AJU Pharma for RBM-007 in Age-related Macular Degeneration
18 Mar 2020 HORAMA Signs Exclusive License Agreement with Leiden University Medical Center Targeting CRB1 Gene Mutations to Treat Inherited Retinal Dystrophies
17 Mar 2020 Eureka Therapeutics Completes $45 Million Series E Financing and Enters into Strategic Collaboration with Lyell Immunopharma

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up